Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02184936 : Measuring Collaterals With Multi-phase CT Angiography in Patients With Ischemic Stroke
PhaseN/A
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

1. Patient presenting to the emergency department with symptoms consistent with ischemic
stroke.

2. Age > 18 yrs.

3. Baseline imaging including multi-phase CTA done within 12 hours of stroke symptom
onset and initiated before recanalization therapy.

4. Evidence of a visible and symptomatic intracranial occlusion on baseline
CT-angiography (intracranial ICA, M1 MCA segment +/- intracranial ICA, proximal M2
MCA).

5. Treatment with IV tPA and/or IA therapy.

Exclusion Criteria:

1. Intracranial hemorrhage (ICH) identified on baseline CT.

2. Previous moderate to large stroke in the ipsilesional hemisphere.

3. Modified Rankin Scale > 2 at baseline.

4. Unable to have CT-angio performed due to recent estimated creatinine clearance
eCCr<60 ml/min, contrast allergy or other reasons.

5. Participation in another study that results in the patient receiving an
investigational drug or therapy.

6. Any terminal illness (patient not expected to survive > 1 year).
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02184936      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740